about
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesBCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line.Inhibition of human immunodeficiency virus (HIV) type 1 multiplication by an avian cellular factor.pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model.Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes.Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cells.Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes.Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo.Identification of JAK2 mutations in canine primary polycythemia.An 8-bp deletion in mNOTCH4 intron 10 leads to its retention in mRNA and to synthesis of a truncated proteinAcceleration of type 1 diabetes mellitus in proinsulin 2–deficient NOD micePurification and characterization of a factor which inhibits retrovirus replicationAcquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression ofc-mycParallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cellsScreening Monoclonal Antibodies against Cell-Surface Antigens High Frequency of Natural AntibodiesEvaluation of residual disease in human leukemias
P50
Q36507980-BFB88786-1769-4DE9-9187-470C9164A4E4Q36544893-4DD0D091-3EC9-4035-961C-16125787A84FQ37235693-E4227B71-9C7E-48E2-9E9E-EDACE2EC45CAQ41120126-CA08E676-CD8A-4C19-A5C4-D2EE8BFE1176Q41651132-5F2564BF-C6AA-447F-9C0E-39488BF01B6FQ42540300-9235A750-05A5-483F-8ADD-67D76D7D2F3EQ43228826-EAA40A4F-079C-4C4A-8FB4-0A7B0068CC10Q44244774-F6CDF052-1A16-49B0-93C5-41476EDB87E8Q45181582-52BE9E13-47F8-46BB-8EED-B306A65CCEE0Q47236450-263B0AE7-4CE0-4072-A0F2-678CFC7AE3A3Q53521826-B9D04FB6-96A0-4BDC-918F-4293EA88BF6FQ54612997-A88C206B-A74D-4D92-8EED-F2D03969FF98Q63383170-42834463-7DCB-40A9-823E-A28B898C642DQ63383172-10D07574-CFE4-409C-BA4F-C730E71AADC2Q63383182-F5CA8D0D-729B-424A-B107-D5CEF7ADF7D6Q63383185-6236DB59-7476-4680-9859-8989F4E12AA6Q63383187-67AEEB09-837E-4BEA-AB21-82A6D33899D1Q63383190-BA1AAEBE-88E3-4D90-A24F-67997D33C662Q63383191-72626146-C6A0-469C-936A-0CD4425F45E7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patricia Krief
@ast
Patricia Krief
@en
Patricia Krief
@es
Patricia Krief
@nl
Patricia Krief
@sl
type
label
Patricia Krief
@ast
Patricia Krief
@en
Patricia Krief
@es
Patricia Krief
@nl
Patricia Krief
@sl
prefLabel
Patricia Krief
@ast
Patricia Krief
@en
Patricia Krief
@es
Patricia Krief
@nl
Patricia Krief
@sl
P1053
M-6073-2014
P106
P21
P31
P3829
P496
0000-0001-5106-466X